{"lastClose": 7.199999809265137, "len": 1096, "date": "2023-02-17", "alpha_1": -0.1546163557260123, "beta_1": 1.6574005250036683, "drawup_1": 1.5486725887776869, "natr_1": 12.195071322632677, "sup_1": -0.6129629686045548, "res_1": 0.27407412901827494, "bullPattern_1": ["SHORTLINE"], "bearPattern_1": [], "rsi_1": 59.74930184525371, "adx_1": 29.394721557730556, "drawdown_1": -0.674768538064794, "stratHoldSharpe_1": -0.01642695976206574, "stratHoldAlpha_1": 250.98857873354922, "stratHoldDrawdown_1": -0.635653301081516, "alpha_3mo": -0.6549333197853315, "beta_3mo": 2.0740492824416648, "drawup_3mo": 0.4608541290620036, "natr_3mo": 12.195071322632677, "sup_3mo": -0.12870365059915254, "res_3mo": 0.021759272198127965, "bullPattern_3mo": [], "bearPattern_3mo": [], "rsi_3mo": 41.57705315215111, "adx_3mo": 35.544576774521055, "drawdown_3mo": -0.4781801627958294, "stratHoldSharpe_3mo": -2.0813747396542825, "stratHoldAlpha_3mo": 249.70440799616568, "stratHoldDrawdown_3mo": -0.43064204643490855, "Sector": "Health Care", "Country": "United States", "Name": "Allogene Therapeutics Inc.", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 1038313109, "IPO Year": 2018.0, "alpha%_1": 0.4037325519451938, "beta%_1": 0.9073118836559291, "drawup%_1": 0.9971768874971526, "natr%_1": 0.9998339125704653, "drawdown%_1": 0.06765379552766838, "stratHoldSharpe%_1": 0.3985081255714932, "stratHoldAlpha%_1": 0.3976357947591706, "stratHoldDrawdown%_1": 0.05483245633017207, "alpha%_3mo": 0.08855926571824196, "beta%_3mo": 0.9769455712618217, "drawup%_3mo": 0.8828394184463753, "natr%_3mo": 0.9997772379332255, "drawdown%_3mo": 2.2592147897634613e-05, "stratHoldSharpe%_3mo": 0.03187450933890284, "stratHoldAlpha%_3mo": 0.001824385138250282, "stratHoldDrawdown%_3mo": 2.8767862442632393e-05}